Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Dunn

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|January 11, 2024
Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and SpacersYixin Jin, Claire Dunn, Irene Persiconi, et al.
International Journal of Molecular Sciences|September 28, 2024
Correction: Jin et al. Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. <i>Int. J. Mol. Sci.</i> 2024, <i>25</i>, 586Yixin Jin, Claire Dunn, Irene Persiconi, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 10, 2020
Small scale design of experiment investigation of equilibrium solubility in simulated fasted and fed intestinal fluidStephanie McPherson, Jeremy Perrier, Claire Dunn, et al.
The Journal of Experimental Medicine|October 12, 2005
Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTLNagendra R Hegde, Claire Dunn, David M Lewinsohn, et al.
Parasitology|July 3, 2023
<i>Haemoproteus</i> parasites and passerines: the effect of local generalists on inferences of host-parasite co-phylogeny in the British IslesCharlie Woodrow, Adina Teodora Rosca, Rachel Fletcher, et al.
The Journal of Experimental Medicine|June 5, 2003
Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicityClaire Dunn, N Jan Chalupny, Claire L Sutherland, et al.
Oncoimmunology|December 20, 2024
Plasma protein dynamics during ipilimumab treatment in metastatic melanoma: associations with tumor response, adverse events and survivalRagnhild Reehorst Lereim, Claire Dunn, Elin Aamdal, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
Inhibition of glycolipid shedding rescues recognition of a CD1+ T cell lymphoma by natural killer T (NKT) cellsVenkataraman Sriram, Sungyoo Cho, Ping Li, et al.
Journal of Virology|October 9, 2002
Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentationNagendra R Hegde, Roman A Tomazin, Todd W Wisner, et al.
Cancers|October 14, 2022
Development of a High-Affinity Antibody against the Tumor-Specific and Hyperactive 611-p95HER2 IsoformEsmaeil Dorraji, Elin Borgen, Dario Segura-Peña, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|January 11, 2024
Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and SpacersYixin Jin, Claire Dunn, Irene Persiconi, et al.
International Journal of Molecular Sciences|September 28, 2024
Correction: Jin et al. Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. <i>Int. J. Mol. Sci.</i> 2024, <i>25</i>, 586Yixin Jin, Claire Dunn, Irene Persiconi, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 10, 2020
Small scale design of experiment investigation of equilibrium solubility in simulated fasted and fed intestinal fluidStephanie McPherson, Jeremy Perrier, Claire Dunn, et al.
The Journal of Experimental Medicine|October 12, 2005
Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTLNagendra R Hegde, Claire Dunn, David M Lewinsohn, et al.
Parasitology|July 3, 2023
<i>Haemoproteus</i> parasites and passerines: the effect of local generalists on inferences of host-parasite co-phylogeny in the British IslesCharlie Woodrow, Adina Teodora Rosca, Rachel Fletcher, et al.
The Journal of Experimental Medicine|June 5, 2003
Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicityClaire Dunn, N Jan Chalupny, Claire L Sutherland, et al.
Oncoimmunology|December 20, 2024
Plasma protein dynamics during ipilimumab treatment in metastatic melanoma: associations with tumor response, adverse events and survivalRagnhild Reehorst Lereim, Claire Dunn, Elin Aamdal, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
Inhibition of glycolipid shedding rescues recognition of a CD1+ T cell lymphoma by natural killer T (NKT) cellsVenkataraman Sriram, Sungyoo Cho, Ping Li, et al.
Journal of Virology|October 9, 2002
Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentationNagendra R Hegde, Roman A Tomazin, Todd W Wisner, et al.
Cancers|October 14, 2022
Development of a High-Affinity Antibody against the Tumor-Specific and Hyperactive 611-p95HER2 IsoformEsmaeil Dorraji, Elin Borgen, Dario Segura-Peña, et al.
Pageof 4